Oppenheimer analyst Leland Gershell downgraded Spruce Biosciences, Inc. (NASDAQ: SPRB) from Outperform to Perform.The analyst comments: "SPRB announced disappointing topline ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE